Miranti Anggun Sari 22010112130164 Lap.KTI Bab7

38

DAFTAR PUSTAKA
1.

Lestari Weny, Wardhani Yurika Fauzia. Stigma dan Penanganan Penderita
Gangguan Jiwa Berat yang Dipasung. 2014;157–66.

2.

Jarut Yulia Maria, Fatimawali, Wiyono Weny. Tinjauan Penggunaan
Antipsikotik Pada Pengobatan Skizofrenia Di Rumah Sakit Prof . Dr . V . L
Ratumbuysang Manado Periode Januari 2013-Maret 2013. Jurnal Ilmiah
Farmasi. 2013;2(03):54–7.

3.

Sadock Benjamin, Sadock Virgnia. Kaplan & Sadock’s Concise Textbook
of Clinical Psychiatry. 2nd ed. Jakarta: EGC; 2013.

4.


Johnson D a W. Historical perspective on antipsychotic long-acting
injections. British Journal of Psychiatry. 2009;195(SUPPL. 52):7–13.

5.

Kane John M, Garcia-Ribera Carlos. Clinical guideline recommendations for
antipsychotic long-acting injections. British Journal of Psychiatry.
2009;195(SUPPL. 52):63–8.

6.

Wistedt Borje. How does the psychiatric patient feel about depot treatment,
compulsion or help. Nordic Journal of Psychiatry [Internet]. Taylor &
Francis;

1995

Jan


1;49(sup35):41–6.

Available

from:

http://www.tandfonline.com/doi/abs/10.3109/08039489509099719
7.

Marwick Katie FM, Taylor Mark, Walker Simon W. Antipsychotics and
abnormal

liver

neuropharmacology

function
[Internet].

tests:


systematic

2012;35(5):244–53.

review.

Clinical

Available

from:

http://www.ncbi.nlm.nih.gov/pubmed/22986798
8.

Bošković Marija, Grabnar Iztok, Terzič Tea, Kores Plesničar Blanka, Vovk
Tomaz. Oxidative stress in schizophrenia patients treated with long-acting
haloperidol decanoate. Psychiatry Research. 2013;210(3):761–8.


9.

Sunarno. The Gluttathion Role As Antioxidant in Inhibition of Neurode
generative Disease and Brain Aging. Semarang; 2009;1(2):185–210.

10.

Bo M, Vovk T, Kores B, Grabnar I. Oxidative Stress in Schizophrenia.
2011;301–12.

11.

Murray RK, Granner DK. Harper’s Illustrated Biochemistry. 27 th. Jakarta:
EGC; 2009.

39

12.

Yu L, Zhao M, Yang B, Zhao Q, Jiang Y. Phenolics from hull of Garcinia

mangostana fruit and their antioxidant activities. Food Chemistry.
2007;104(1):176–81.

13.

Mansour NAA, Aulani’am, Kusnadi J. Garciniamangostana Linn . Pericarp
Extract Reduced Malondialdehyde ( MDA ) Level in Cigarette Smoke
Exposed Rats. 2013;2(9):1–5.

14.

Tjahjani S, Widowati W, Khiong K, Suhendra A, Tjokropranoto R.
Antioxidant Properties of Garcinia Mangostana L (Mangosteen) Rind.
Procedia Chemistry [Internet]. Elsevier Ltd.; 2014 [cited 2015 Dec
23];13(2009):198–203.

Available

from:


http://linkinghub.elsevier.com/retrieve/pii/S1876619614002162
15.

Gumulec J, Raudenska M, Hlavna M, Stracina T, Sztalmachova M,
Tanhauserova V, et al. Determination of oxidative stress and activities of
antioxidant enzymes in guinea pigs treated with haloperidol. Experimental
and therapeutic medicine [Internet]. 2013;5(2):479–84. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3570091&tool=
pmcentrez&rendertype=abstract

16.

Meltzer H. Antipsychotic Agents & Lithium. In: Katzung BG, editor. Basic
and clinical Pharmacology. 12 th. San Francisco: McGraw-Hill; 2012. p.
501–20.

17.

Brissos S, Veguilla MR, Taylor D, Balanzá-martinez V. Therapeutic
Advances in Psychopharmacology The role of long-acting injectable

antipsychotics in schizophrenia : a critical appraisal. 2014;

18.

Olivares JM, Pinal B, Cinos C. Comparison of long-acting antipsychotic
injection and oral antipsychotics in schizophrenia. Neuropsychiatry
[Internet].

2011;1(3):275–89.

Available

from:

http://www.embase.com/search/results?subaction=viewrecord&from=expor
t&id=L364450714\nhttp://dx.doi.org/10.2217/npy.11.24
19.

William Z. Potter LEH. Drugs that act in the central nervous system. In:
Bertram G. Katzung, editor. Basic & Clinical Pharmacology. 12 th. United

States of America: The McGraw-Hill Companies; 2012.

40

20.

Henryk-gutt R. The Effect of Flufenazin dekanoat ( Modecater ) on Hepatic
Microsomal Enzyme Activity in Man. Br J clin Pharmac. 1974;1:1973–4.

21.

Jung H-A, Su B-N, Keller WJ, Mehta RG, Kinghorn AD. Antioxidant
Xanthones from the Pericarp of Garcinia mangostana (Mangosteen).
Agriculture and Food Chemistry. 2006;54:2077–82.

22.

Weecharangsan W, Opanasopit P, Sukma M, Ngawhirunpat T, Sotanaphun
U, Siripong P. Antioxidative and neuroprotective activities of extracts from
the fruit hull of mangosteen (Garcinia mangostana Linn.). Medical Principles

and Practice. 2006;15(4):281–7.

23.

Azzahra H, Pujiastuti P. Potensi Ekstrak Kulit Buah Manggis ( Garcinia
mangostana L .) Buatan Pabrik Terhadap Peningkatan Aktivitas
Mikrobisidal Sel Neutrofil yang Dipapar Streptococcus mutans ( The
Potency of Manufactured Mangosteen Peel Extract ( Garcin- ia mangostana
L .) Towa. 2014;2(1):161–6.

24.

Jujun P, Pootakham K, Pongpaibul Y, Duangrat C, Tharavichitkul P. Acute
and repeated dose 28-day oral toxicity study of Garcinia mangostana Linn
rind extract. J Nat Sci. 2008;7:206–199.

25.

Chen C-H. Activation and Detoxification Enzymes. New York: Springer;
2012.


26.

Ho E, Karimi Galougahi K, Liu C-C, Bhindi R, Figtree GA. Biological
markers of oxidative stress: Applications to cardiovascular research and
practice. Redox Biology [Internet]. Elsevier; 2013 [cited 2016 Jan
12];1(1):483–91.

Available

from:

http://linkinghub.elsevier.com/retrieve/pii/S221323171300058X
27.

Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress
and antioxidant defense. The World Allergy Organization journal [Internet].
2012;5(1):9–19. Available from: http://www.waojournal.org/content/5/1/9

28.


Jarut YM, Fatimawali, Wiyono WI. Tinjauan Penggunaan Antipsikotik Pada
Pengobatan Skizofrenia Di Rumah Sakit Prof . Dr . V . L . Jurnal Ilmiah
Farmasi. 2013;2(03):54–7.

29.

Weydert CJ, Cullen JJ. Measurement of Superoxide Dismutase, Catalase,

41

and Glutathione Peroxidase in Cultured Cells and Tissue. Nat Protoc.
2010;5(1):51–66.
30.

N.a. General Guidelines for Methodologies on Research and Evaluation of
Traditional
Organization

Medicine

World

(WHO)

Health

[Internet].

Organization.

2000;1:1–71.

World

Health

Available

from:

http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:General+
Guidelines+for+Methodologies+on+Research+and+Evaluation+of+Traditi
onal+Medicine+World+Health+Organization#0
31.

Kuribara H, Tadokoro S. Study of Accummulation of Fluphenazine
Enanthate and Flufenazin dekanoat, Long Acting Neuropletic Drugs, After
Repeated Administrarions By Means of Their Inhibitory Effects on the
Discriminated Avoidance Response in Rats. The Journal of Toxicological
Sciences. 1978;4:87–9.

32.

Iwase T, Tajima A, Sugimoto S, Okuda K, Hironaka I, Kamata Y, et al. A
simple assay for measuring catalase activity: a visual approach. Scientific
reports

[Internet].

2013;3(January

2016):3081.

Available

from:

http://www.nature.com/srep/2013/131030/srep03081/full/srep03081.html
33.

Cadet JL, Perumal AS. Chronic treatment with prolixin causes oxidative
stress in rat brain. Biological Psychiatry. 1990;28:738–40.

34.

Henryk-gutt R. The Effect of Fluphanzine decanoat (Modecater) on Hepatic
Microsomal Enzyme Activity in Man. Br J clin Pharmac. 1974;1:277–8.

35.

Cichoz-Lach H, Michalak A. Oxidative stress as a crucial factor in liver
diseases. World Journal of Gastroenterology. 2014;20(25):8082–91.

36.

Pedraza-Chaverri J, C??rdenas-Rodr??guez N, Orozco-Ibarra M, P??rezRojas JM. Medicinal properties of mangosteen (Garcinia mangostana). Food
and Chemical Toxicology [Internet]. Elsevier Ltd; 2008;46(10):3227–39.
Available from: http://dx.doi.org/10.1016/j.fct.2008.07.024

37.

Azzahra H, Pujiastuti P, Gigi FK, Jember U, Periodonsia B, Gigi FK, et al.
Potensi Ekstrak Kulit Buah Manggis ( Garcinia mangostana L .) Buatan
Pabrik Terhadap Peningkatan Aktivitas Mikrobisidal Sel Neutrofil yang
Dipapar Streptococcus mutans ( The Potency of Manufactured Mangosteen

42

Peel Extract ( Garcin- ia mangostana L .) Towa. 2014;2(1):161–6.
38.

Veeraraghavan VP, Mohan SK, Jainu M, Gopan CS. Ameliorating effects of
Garcinia mangostana Linn pericarp extract on hepatic antioxidants in Diethyl
nitrosamine ( DEN ) induced Hepatocellular Carcinoma ( HCC ).
2015;49(4).

39.

Pal PB, Sinha K, Sil PC. Mangiferin, a Natural Xanthone, Protects Murine
Liver in Pb(II) Induced Hepatic Damage and Cell Death via MAP Kinase,
NF-??B and Mitochondria Dependent Pathways. PLoS ONE. 2013;8(2):1–
17.

40.

Dash DK, Yeligar VC, Nayak SS, Ghosh T, Rajalingam R, Sengupta P, et al.
Evaluation of hepatoprotective and antioxidant activity of {Ichnocarpus}
frutescens ({Linn}.) {R}.{Br}. on paracetamol-induced hepatotoxicity in
rats. Tropical Journal of Pharmaceutical Research [Internet]. 2007;6(3):755–
65. Available from: http://www.ajol.info/index.php/tjpr/article/view/14656

41.

Dewi MR. Pengaruh Hepatoprotektor Madu Terhadap Kerusakan Histologis
Sel Hepar Mencit ( Mus musculus ) Yang Diberi Perlakuan Natrium. 2010;

42.

Oyejide OJOO, Olushola L. Hepatoprotective and antioxidant properties of
extract of Carmellia sinensis (Black tea) in rats. Journal of Biotechnology.
2005;4(December):1432–8.

43.

Lohr JB, Kuczenski R, Niculescu AB. Oxidative mechanisms and tardive
dyskinesia. CNS Drugs. 2003;17(1):47–62.

43

Lampiran 1 Penghitungan dosis flufenazin dekanoat
Setiap 1 ampul berisi 25 mg Flufenazin dekanoat, dilarutkan menggunakan
sesame oil 10 ml yang telah disterilkan. Penghitungan dosis menggunakan
rumus:
� �



� �� ��









Penghitungan dosis Flufenazin dekanoat 2 mg/kgBB

Berat tikus (kg)



�….



Dosis 2 mg/kgBB

0,19

0,152

0,20

0,16

0,21

0,168

0,22

0,176

0,23

0,184

0,24

0,192

0,25

0,2

0,26

0,208

0,27

0,216

0,28

0,224

0,29

0,232

0,30

0,240





44

Lampiran 2 Penghitungan dosis ekstrak kulit manggis
Setiap 1 kaplet berisi 500 mg ekstrak kulit manggis, dilarutkan menggunakan
etanol 1 %.
Dosis yang digunakan adalah 600 mg/kgBB.13
Berat badan tikus ± 200 mg = 0,2 kg
Dosis ekstrak kulit manggis untuk tikus adalah adalah
� �

=

=


× ,
���






���

��

����

×





Dilarutkan dengan 30 ml etanol 1% disesuaikan dengan kapasitas minum tikus.

45

Lampiran 3 Ethical clearance

46

Lampiran 4 Surat Ijin Penelitian

47

Lampiran 5 Analisis data
Descriptives
kelompok

Statistic

Mean

2,5500
Lower Bound

1,6085

Upper Bound

3,4915

Std. Error
,33912

95% Confidence Interval for Mean
5% Trimmed Mean

2,5556

Median

2,5000

Variance
k0

,575

Std. Deviation

,75829

Minimum

1,50

Maximum

3,50

Range

2,00

Interquartile Range

1,38

Skewness

-,226

,913

Kurtosis

-,139

2,000

5,8200

,76560

Mean
Lower Bound

3,6943

Upper Bound

7,9457

95% Confidence Interval for Mean
katalase
5% Trimmed Mean

5,8222

Median

5,2500

Variance
p1

2,931

Std. Deviation

1,71194

Minimum

3,60

Maximum

8,00

Range

4,40

Interquartile Range

3,08

Skewness

,057

,913

-,865

2,000

8,3000

1,54394

Kurtosis
Mean
Lower Bound

4,0133

Upper Bound

12,5867

95% Confidence Interval for Mean
p2
5% Trimmed Mean

8,2083

Median

8,0000

Variance

11,919

48

Std. Deviation

3,45235

Minimum

5,00

Maximum

13,25

Range

8,25

Interquartile Range

6,50

Skewness

,626

,913

-,839

2,000

10,1700

,89521

Kurtosis
Mean
Lower Bound

7,6845

Upper Bound

12,6555

95% Confidence Interval for Mean
5% Trimmed Mean

10,2583

Median

10,6000

Variance
k1

4,007

Std. Deviation

2,00175

Minimum

6,75

Maximum

12,00

Range

5,25

Interquartile Range

2,88

Skewness

-1,724

,913

3,564

2,000

Kurtosis

Tests of Normality
kelompok

Kolmogorov-Smirnova
Statistic

df

Sig.

Statistic

df

Sig.

k0

,146

5

,200*

,992

5

,985

p1

,230

5

,200*

,955

5

,776

p2

,212

5

,200*

,922

5

,543

k1

,365

5

,028

,813

5

,103

katalase

*. This is a lower bound of the true significance.
a. Lilliefors Significance Correction

Test of Homogeneity of Variances
katalase

Shapiro-Wilk

49

Levene Statistic
2,703

df1

df2
3

Sig.
16

,080

ANOVA
katalase
Sum of Squares
Between Groups

Mean Square

162,987

3

54,329

77,726

16

4,858

240,713

19

Within Groups
Total

df

F

Sig.

11,184

,000

Multiple Comparisons
Dependent Variable: katalase
Bonferroni
(I) kelompok

(J) kelompok

Mean

Std. Error

Sig.

Difference (I-J)

k0

p1

p2

k1

95% Confidence Interval
Lower Bound

Upper Bound

p1

-3,27000

1,39397

,193

-7,4635

,9235

p2

-5,75000*

1,39397

,005

-9,9435

-1,5565

k1

-7,62000*

1,39397

,000

-11,8135

-3,4265

k0

3,27000

1,39397

,193

-,9235

7,4635

p2

-2,48000

1,39397

,565

-6,6735

1,7135

k1

-4,35000*

1,39397

,040

-8,5435

-,1565

k0

5,75000*

1,39397

,005

1,5565

9,9435

p1

2,48000

1,39397

,565

-1,7135

6,6735

k1

-1,87000

1,39397

1,000

-6,0635

2,3235

k0

7,62000*

1,39397

,000

3,4265

11,8135

p1

4,35000*

1,39397

,040

,1565

8,5435

p2

1,87000

1,39397

1,000

-2,3235

6,0635

*. The mean difference is significant at the 0.05 level.

50

Lampiran 6 Dokumentasi

51

52

53

54

55

Lampiran 7 Biodata mahasiswa
Identitas
Nama

: Miranti Anggun Sari

NIM

: 22010112130164

Tempat/tanggal lahir

: Semarang, 25 Agustus 1994

Jenis Kelamin

: Perempuan

Nomor HP

: 089679094604

e-mail

: miranggun@gmail.com

Riwayat Pendidikan Formal
1. SD

: SD Hj Isriati Baiturrahman Semarang Lulus tahun: 2006

2. SMP

: SMP N 8 Semarang

Lulus tahun: 2009

3. SMA

: SMA N 1 Semarang

Lulus tahun: 2012

4. FK UNDIP

: Masuk tahun : 2012